These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 30387480)
41. Gd (III) complex conjugate of low-molecular-weight chitosan as a contrast agent for magnetic resonance/fluorescence dual-modal imaging. Huang Y; Boamah PO; Gong J; Zhang Q; Hua M; Ye Y Carbohydr Polym; 2016 Jun; 143():288-95. PubMed ID: 27083371 [TBL] [Abstract][Full Text] [Related]
42. Naphthyridine-based lanthanide complexes worked as magnetic resonance imaging contrast for guanosine 5'-monophosphate in vivo. Kong J; Liu T; Bao Y; Jin K; Zhang X; Tang Q; Duan C Talanta; 2013 Dec; 117():412-8. PubMed ID: 24209361 [TBL] [Abstract][Full Text] [Related]
43. Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity. Parac-Vogt TN; Kimpe K; Laurent S; Vander Elst L; Burtea C; Chen F; Muller RN; Ni Y; Verbruggen A; Binnemans K Chemistry; 2005 May; 11(10):3077-86. PubMed ID: 15776492 [TBL] [Abstract][Full Text] [Related]
44. A Responsive Magnetic Resonance Imaging Contrast Agent for Detection of Excess Copper(II) in the Liver Paranawithana NN; Martins AF; Clavijo Jordan V; Zhao P; Chirayil S; Meloni G; Sherry AD J Am Chem Soc; 2019 Jul; 141(28):11009-11018. PubMed ID: 31268706 [TBL] [Abstract][Full Text] [Related]
45. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents. Laus S; Ruloff R; Tóth E; Merbach AE Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682 [TBL] [Abstract][Full Text] [Related]
46. Outer-sphere investigation of MRI relaxation contrast agents. Example of a cyclodecapeptide gadolinium complex with second-sphere water. Bonnet CS; Fries PH; Crouzy S; Delangle P J Phys Chem B; 2010 Jul; 114(26):8770-81. PubMed ID: 20552972 [TBL] [Abstract][Full Text] [Related]
47. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon. Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679 [TBL] [Abstract][Full Text] [Related]
48. Mechanistic studies of a calcium-dependent MRI contrast agent. Li WH; Parigi G; Fragai M; Luchinat C; Meade TJ Inorg Chem; 2002 Jul; 41(15):4018-24. PubMed ID: 12132928 [TBL] [Abstract][Full Text] [Related]
49. Selective anchoring of Gd(III) chelates on the external surface of organo-modified mesoporous silica nanoparticles: a new chemical strategy to enhance relaxivity. Carniato F; Tei L; Arrais A; Marchese L; Botta M Chemistry; 2013 Jan; 19(4):1421-8. PubMed ID: 23233428 [TBL] [Abstract][Full Text] [Related]
50. Chiral Pyclen-Based Heptadentate Chelates as Highly Stable MRI Contrast Agents. Jian Y; Mo G; Xu W; Liu Y; Zhang Z; Ding Y; Gao R; Xu J; Zhu J; Shu K; Yan Z; Carniato F; Platas-Iglesias C; Ye F; Botta M; Dai L Inorg Chem; 2024 May; 63(18):8462-8475. PubMed ID: 38642052 [TBL] [Abstract][Full Text] [Related]
51. Comparison of a tartaric acid derived polymeric MRI contrast agent to a small molecule model chelate. Lucas RL; Benjamin M; Reineke TM Bioconjug Chem; 2008 Jan; 19(1):24-7. PubMed ID: 18092744 [TBL] [Abstract][Full Text] [Related]
52. Convenient synthesis of (68)Ga-labeled gadolinium(III) complexes: towards bimodal responsive probes for functional imaging with PET/MRI. Notni J; Hermann P; Dregely I; Wester HJ Chemistry; 2013 Sep; 19(38):12602-6. PubMed ID: 24175335 [TBL] [Abstract][Full Text] [Related]
53. Activatable T₁ and T₂ magnetic resonance imaging contrast agents. Tu C; Osborne EA; Louie AY Ann Biomed Eng; 2011 Apr; 39(4):1335-48. PubMed ID: 21331662 [TBL] [Abstract][Full Text] [Related]
54. Gadolinium-Decorated Silica Microspheres as Redox-Responsive MRI Probes for Applications in Cell Therapy Follow-Up. Muñoz Úbeda M; Carniato F; Catanzaro V; Padovan S; Grange C; Porta S; Carrera C; Tei L; Digilio G Chemistry; 2016 Jun; 22(23):7716-20. PubMed ID: 27037861 [TBL] [Abstract][Full Text] [Related]
56. A multimeric MR-optical contrast agent for multimodal imaging. Harrison VS; Carney CE; Macrenaris KW; Meade TJ Chem Commun (Camb); 2014 Oct; 50(78):11469-71. PubMed ID: 25137290 [TBL] [Abstract][Full Text] [Related]
57. Synthesis, relaxivity, and in vitro fluorescence imaging studies of a novel d-f heterometallic trinuclear complex as a potential bimodal imaging probe for MRI and optical imaging. Nithyakumar A; Alexander V Dalton Trans; 2015 Oct; 44(40):17800-9. PubMed ID: 26400754 [TBL] [Abstract][Full Text] [Related]
58. Redox- and hypoxia-responsive MRI contrast agents. Do QN; Ratnakar JS; Kovács Z; Sherry AD ChemMedChem; 2014 Jun; 9(6):1116-29. PubMed ID: 24825674 [TBL] [Abstract][Full Text] [Related]
59. Gadolinium(III) complexes of 1,4,7-triazacyclononane based picolinate ligands: simultaneous optimization of water exchange kinetics and electronic relaxation. Nonat A; Giraud M; Gateau C; Fries PH; Helm L; Mazzanti M Dalton Trans; 2009 Oct; (38):8033-46. PubMed ID: 19771367 [TBL] [Abstract][Full Text] [Related]